{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T11:25:31Z","timestamp":1747221931153,"version":"3.40.5"},"reference-count":28,"publisher":"Sociedade Brasileira de Pneumologia e Tisiologia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bras Pneumol."],"abstract":"<jats:p>Objective: There is still limited information on the clinical characteristics and outcomes of cystic fibrosis (CF) patients with COVID-19 in Brazil. The objective of this study was to describe the cumulative incidence of COVID-19 in CF patients, as well as their clinical characteristics and outcomes. Methods: This was a prospective cohort study involving unvaccinated adult CF patients and conducted during the first year of the SARS-CoV-2 pandemic in the city of Porto Alegre, in southern Brazil. The clinical course of the disease was rated on the WHO Ordinal Scale for Clinical Improvement. The primary outcome was the number of incident cases of COVID-19. Results: Between April 30, 2020 and April 29, 2021, 98 CF patients were included in the study. Seventeen patients were diagnosed with COVID-19. For the CF patients, the annual cumulative incidence of COVID-19 was 17.3%, similar to that for the general population, adjusted for age (18.5%). The most common symptoms at diagnosis of COVID-19 were cough (in 59%), dyspnea (in 53%), fatigue (in 53%), and fever (in 47%). Only 6 (35%) of the patients required hospitalization, and 3 (17.6%) required oxygen support. Only 1 patient required mechanical ventilation, having subsequently died. Conclusions: During the first year of the SARS-CoV-2 pandemic in southern Brazil, the cumulative incidence rate of COVID-19 was similar between CF patients and the general population. More than 50% of the CF patients with SARS-CoV-2 infection had a mild clinical presentation, without the need for hospital admission, and almost the entire sample recovered completely from the infection, the exception being 1 patient who had advanced lung disease and who died.<\/jats:p>","DOI":"10.36416\/1806-3756\/e20220265","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T18:45:17Z","timestamp":1668192317000},"page":"e20220265","source":"Crossref","is-referenced-by-count":1,"title":["Clinical characteristics and outcomes of incident cases of COVID-19 in unvaccinated adult cystic fibrosis patients in southern Brazil: a prospective cohort study conducted during the first year of the COVID-19 pandemic"],"prefix":"10.36416","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4234-6125","authenticated-orcid":false,"given":"Cristiane","family":"Christ Camargo1,2","sequence":"first","affiliation":[{"name":"1. Hospital de Cl\u00ednicas de Porto Alegre, Porto Alegre (RS) Brasil. 2. Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias Pneumol\u00f3gicas, Universidade Federal do Rio Grande do Sul \u2013 UFRGS \u2013 Porto Alegre (RS) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0624-456X","authenticated-orcid":false,"given":"Let\u00edcia","family":"Bauer Jacobsen3","sequence":"additional","affiliation":[{"name":"3. Faculdade de Nutri\u00e7\u00e3o, Universidade Federal do Rio Grande do Sul \u2013 UFRGS \u2013 Porto Alegre (RS) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3406-098X","authenticated-orcid":false,"given":"Jaqueline","family":"Wilsmann3","sequence":"additional","affiliation":[{"name":"3. Faculdade de Nutri\u00e7\u00e3o, Universidade Federal do Rio Grande do Sul \u2013 UFRGS \u2013 Porto Alegre (RS) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0984-8169","authenticated-orcid":false,"given":"Michelle","family":"Nunes Silveira1,2","sequence":"additional","affiliation":[{"name":"1. Hospital de Cl\u00ednicas de Porto Alegre, Porto Alegre (RS) Brasil. 2. Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias Pneumol\u00f3gicas, Universidade Federal do Rio Grande do Sul \u2013 UFRGS \u2013 Porto Alegre (RS) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7177-7085","authenticated-orcid":false,"given":"Bruna","family":"Ziegler1,2","sequence":"additional","affiliation":[{"name":"1. Hospital de Cl\u00ednicas de Porto Alegre, Porto Alegre (RS) Brasil. 2. Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias Pneumol\u00f3gicas, Universidade Federal do Rio Grande do Sul \u2013 UFRGS \u2013 Porto Alegre (RS) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2175-7083","authenticated-orcid":false,"given":"Elis","family":"de Pellegrin Rossi1","sequence":"additional","affiliation":[{"name":"1. Hospital de Cl\u00ednicas de Porto Alegre, Porto Alegre (RS) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2119-7992","authenticated-orcid":false,"given":"Carla","family":"Tatiana Oliveira1","sequence":"additional","affiliation":[{"name":"1. Hospital de Cl\u00ednicas de Porto Alegre, Porto Alegre (RS) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9774-9135","authenticated-orcid":false,"given":"Paulo","family":"de Tarso Roth Dalcin1,2","sequence":"additional","affiliation":[{"name":"1. Hospital de Cl\u00ednicas de Porto Alegre, Porto Alegre (RS) Brasil. 2. Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias Pneumol\u00f3gicas, Universidade Federal do Rio Grande do Sul \u2013 UFRGS \u2013 Porto Alegre (RS) Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22288","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1.            World Health Organization (WHO) [homepage on the Internet]. Geneva: WHO; c2021 [updated 2020 Feb 12; cited 2021 Apr 4]. COVID-19 Public Health Emergency of International Concern (PHEIC). Global research and innovation forum. Available from: https:\/\/www.who.int\/publications\/m\/item\/covid-19-public-health-emergency-of-international-concern-(pheic)-global-research-and-innovation-forum","DOI":"10.31237\/osf.io\/vn4m8"},{"key":"ref1","unstructured":"2.            Mitchell A, Chiwele I, editors. Coronavirus Disease 2019 (COVID-19). BMJ Best Practice. BMC Publishing Group; 2021."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"3.            Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547. https:\/\/doi.org\/10.1183\/13993003.00547-2020","DOI":"10.1183\/13993003.01227-2020"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"4.            Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy [published correction appears in JAMA. 2021 May 25;325(20):2120]. JAMA. 2020;323(16):1574-1581. https:\/\/doi.org\/10.1001\/jama.2020.5394","DOI":"10.1001\/jama.2020.4031"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5.            Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published correction appears in Lancet. 2020 Mar 28;395(10229):1038] [published correction appears in Lancet. 2020 Mar 28;395(10229):1038]. Lancet. 2020;395(10229):1054-1062. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3","DOI":"10.1016\/s0140-6736(20)30566-3"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6.            Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA [published correction appears in Science 1989 Sep 29;245(4925):1437]. Science. 1989;245(4922):1066-1073. https:\/\/doi.org\/10.1126\/science.2475911","DOI":"10.1126\/science.2475911"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7.            Elborn JS. Cystic fibrosis. Lancet. 2016;388(10059):2519-2531. https:\/\/doi.org\/10.1016\/S0140-6736(16)00576-6","DOI":"10.1016\/s0140-6736(16)00576-6"},{"key":"ref7","unstructured":"8.            Fainardi V, Longo F, Chetta A, Esposito S, Pisi G. Sars-CoV-2 infection in patients with cystic fibrosis. An overview. Acta Biomed. 2020;91(3):e2020035."},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"9.            Bhatt JM. Treatment of pulmonary exacerbations in cystic fibrosis. Eur Respir Rev. 2013;22(129):205-216. https:\/\/doi.org\/10.1183\/09059180.00006512","DOI":"10.1183\/09059180.00006512"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10.          Flume PA, Mogayzel PJ Jr, Robinson KA, Goss CH, Rosenblatt RL, Kuhn RJ, et al. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am J Respir Crit Care Med. 2009;180(9):802-808. https:\/\/doi.org\/10.1164\/rccm.200812-1845PP","DOI":"10.1164\/rccm.200812-1845pp"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11.          Wat D, Gelder C, Hibbitts S, Cafferty F, Bowler I, Pierrepoint M, et al. The role of respiratory viruses in cystic fibrosis. J Cyst Fibros. 2008;7(4):320-328. https:\/\/doi.org\/10.1016\/j.jcf.2007.12.002","DOI":"10.1016\/j.jcf.2007.12.002"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12.          Viviani L, Assael BM, Kerem E; ECFS (A) H1N1 study group. Impact of the A (H1N1) pandemic influenza (season 2009-2010) on patients with cystic fibrosis. J Cyst Fibros. 2011;10(5):370-376. https:\/\/doi.org\/10.1016\/j.jcf.2011.06.004","DOI":"10.1016\/j.jcf.2011.06.004"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13.          Brasil. Minist\u00e9rio da Sa\u00fade. Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (ANVISA) [homepage on the Internet]. Bras\u00edlia: ANVISA [updated 2022 Jun 30 cited 2022 Jun 30]. Portos, aeroportos e fronteiras. Coronav\u00edrus. Linha do tempo. Available from: https:\/\/www.gov.br\/anvisa\/pt-br\/assuntos\/paf\/coronavirus\/linha-do-tempo","DOI":"10.22239\/2317-269x.01481"},{"key":"ref13","unstructured":"14.          Biernath A. Um ano de coronav\u00edrus no Brasil: os bastidores da descoberta do primeiro caso oficial. BBC News Brasil [homepage on the Internet]. 2021 Feb 25. Available from: https:\/\/www.bbc.com\/portuguese\/brasil-56189539"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15.          Brasil. Estado do Rio Grande do Sul. Secretaria de Vigil\u00e2ncia em Sa\u00fade [homepage on the Internet]. Porto Alegre: Secretaria de Vigil\u00e2ncia em Sa\u00fade; c2020 [updated 2020 Mar 10; cited 2020 Mar 10] Confirmado o primeiro caso de novo coronav\u00edrus no Rio Grande do Sul. Available from: https:\/\/saude.rs.gov.br\/confirmado-o-primeiro-caso-de-novo-coronavirus-no-rio-grande-do-sul","DOI":"10.29381\/0103-8559\/2020300182-6"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16.          Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, et al. Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation [published correction appears in J Pediatr. 2017 May;184:243]. J Pediatr. 2017;181S:S4-S15.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2016.09.064","DOI":"10.1016\/j.jpeds.2016.09.064"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"17.          Pereira CA, Sato T, Rodrigues SC. New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol. 2007;33(4):397 406. https:\/\/doi.org\/10.1590\/S1806-37132007000400008","DOI":"10.1590\/S1806-37132007000400008"},{"key":"ref17","unstructured":"18.          World Health Organization (WHO) [homepage on the Internet]. Geneva: WHO; c2020 [updated 2020 Feb 18; cited 2020 Apr 22]. COVID-19 Therapeutic Trial Synopsis. Available from: https:\/\/www.who.int\/publications\/i\/item\/covid-19-therapeutic-trial-synopsis"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19.          Brasil. Estado do Rio Grande do Sul. Secretaria de Vigil\u00e2ncia em Sa\u00fade [homepage on the Internet]. Porto Alegre: Secretaria de Vigil\u00e2ncia em Sa\u00fade; c2021 [updated 2022 Apr 12; cited 2021 Apr 29]. Boletim Epidemiol\u00f3gico Covid-19. Available from: https:\/\/coronavirus.rs.gov.br\/informe-epidemiologico","DOI":"10.22239\/2317-269x.01853"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20.          Colombo C, Burgel PR, Gartner S, van Koningsbruggen-Rietschel S, Naehrlich L, Sermet-Gaudelus I, et al. Impact of COVID-19 on people with cystic fibrosis. Lancet Respir Med. 2020;8(5):e35-e36. https:\/\/doi.org\/10.1016\/S2213-2600(20)30177-6","DOI":"10.1016\/s2213-2600(20)30177-6"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"21.          Cosgriff R, Ahern S, Bell SC, Brownlee K, Burgel PR, Byrnes C, et al. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis. J Cyst Fibros. 2020;19(3):355-358. https:\/\/doi.org\/10.1016\/j.jcf.2020.04.012","DOI":"10.1016\/j.jcf.2020.04.012"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22.          Bezzerri V, Lucca F, Volpi S, Cipolli M. Does cystic fibrosis constitute an advantage in COVID-19 infection?. Ital J Pediatr. 2020;46(1):143. https:\/\/doi.org\/10.1186\/s13052-020-00909-1","DOI":"10.1186\/s13052-020-00909-1"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23.          Corvol H, de Miranda S, Lemonnier L, Kemgang A, Reynaud Gaubert M, Chiron R, et al. First Wave of COVID-19 in French Patients with Cystic Fibrosis. J Clin Med. 2020;9(11):3624. https:\/\/doi.org\/10.3390\/jcm9113624","DOI":"10.3390\/jcm9113624"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24.          Mondejar-Lopez P, Quintana-Gallego E, Giron-Moreno RM, Cortell-Aznar I, Ruiz de Valbuena-Maiz M, Diab-Caceres L, et al. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey. Respir Med. 2020;170:106062. https:\/\/doi.org\/10.1016\/j.rmed.2020.106062","DOI":"10.1016\/j.rmed.2020.106062"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25.          Colombo C, Alicandro G, Dacc\u00f3 V, Gagliano V, Morlacchi LC, Casciaro R, et al. SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020. PLoS One. 2021;16(5):e0251527. https:\/\/doi.org\/10.1371\/journal.pone.0251527","DOI":"10.1371\/journal.pone.0251527"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"26.          Naehrlich L, Orenti A, Dunlevy F, Kasmi I, Harutyunyan S, Pfleger A, et al. Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020. J Cyst Fibros. 2021;20(4):566-577. https:\/\/doi.org\/10.1016\/j.jcf.2021.03.017","DOI":"10.1016\/j.jcf.2021.03.017"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27.          Mathew HR, Choi MY, Parkins MD, Fritzler MJ. Systematic review: cystic fibrosis in the SARS-CoV-2\/COVID-19 pandemic. BMC Pulm Med. 2021;21(1):173. https:\/\/doi.org\/10.1186\/s12890-021-01528-0","DOI":"10.1186\/s12890-021-01528-0"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"28.          McClenaghan E, Cosgriff R, Brownlee K, Ahern S, Burgel PR, Byrnes CA, et al. The global impact of SARS-CoV-2 in 181 people with cystic fibrosis. J Cyst Fibros. 2020;19(6):868-871. https:\/\/doi.org\/10.1016\/j.jcf.2020.10.003","DOI":"10.1016\/j.jcf.2020.10.003"}],"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T18:45:23Z","timestamp":1668192323000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jornaldepneumologia.com.br\/details\/3766\/en-US\/clinical-characteristics-and-outcomes-of-incident-cases-of-covid-19-in-unvaccinated-adult-cystic-fibrosis-patients-in-southern-brazil--a-prospective-c"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":28,"URL":"https:\/\/doi.org\/10.36416\/1806-3756\/e20220265","relation":{},"ISSN":["1806-3756"],"issn-type":[{"type":"electronic","value":"1806-3756"}],"subject":[],"published":{"date-parts":[[2022,11,11]]}}}